Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
Onera Health, pioneer and leader in remote sleep diagnostic and monitoring solutions enabling clinicians to conduct sleep studies anytime, anywhere, announces the completion of a Series C financing round, , led by EQT Life Sciences, co-led by Gimv and supported by existing investors Innovation Industries, Invest-NL, Imec.xpand, BOM, and 15th Rock.
Onera Health focuses on breakthrough sleep testing solutions that are quick, convenient, and clinically accurate. The user-centric technology of their polysomnography (PSG) system brings clinical-grade PSG diagnostics and monitoring directly to the patient’s bed while being in the comfort of their own home (hPSG). The MedTech and Digital Health company is currently operating in the United States, the Benelux, and the DACH region.
This Series C financing round allows Onera Health to accelerate manufacturing and sales to meet the growing customer demand for its innovative, self-applied, no-wire end-to-end solution. Furthermore, the company has the clear ambition to become the leader in hPSG within the field of sleep medicine via its next-generation PSG system for which clearance procedures are pending in Europe and the United States.
Michaël Vlemmix and Sandy Blin, Partner and Analyst in the Gimv Life Sciences platform, jointly indicate: “Onera Health is run by a highly skilled management team that has been able to further leverage cutting edge technology which stems from the Imec research center. We believe the company’s solution has the potential to disrupt the sleep testing market by bringing complex polysomnography studies at home, which will reduce the patient backlog in hospitals and facilitate the diagnosis of sleep diseases which incidence is steadily increasing every year. Together with a solid international investor base, we are thus looking forward to supporting the development of such a breakthrough solution.”
Bram Vanparys, Managing Partner – Head of Life Sciences at Gimv, adds: ”The mission of Gimv’s Life Sciences platform is to invest in companies that develop products that positively impact our wellbeing and, in parallel improve the efficiency of our healthcare system. Onera Health is a perfect example of how innovative technology leads to more efficient diagnosis which will benefit both the patient and the affordability of healthcare.”
For more information, please read the full press release from Onera Health attached.